Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Milestone Pharmaceuticals Inc. (MIST)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17
   10-K10-K10-K10-K/AS-1/A
Cash flows used in operating activities       
Net loss  -42.9-50.0-55.2-23.2 
   
Adjustments to reconcile net loss to net cash used in operating activities:       
    Depreciation of property and equipment  0.10.10.00.0 
    Share-based compensation expense  7.34.91.20.6 
    Changes in operating assets and liabilities:       
        Other receivables  0.10.00.1-0.3 
        Research and development tax credits receivable  0.4-0.1-0.30.1 
        Prepaid expenses  1.1-3.6-0.4-1.3 
        Accounts payable and accrued liabilities  0.6-2.13.52.9 
            Net cash used in operating activities  -33.2-50.7-51.2-21.0 
   
Cash provided by (used in) investing activities       
Acquisition of property and equipment    -0.40.0 
Acquisition of short-term investments  -15.0-90.0-35.0-3.0 
Redemption of short-term investments  85.020.035.019.00.0
    Net cash provided by (used in) investing activities  70.0-70.0-0.416.0 
   
Cash provided by financing activities       
Proceeds from exercise of options  0.10.30.00.5 
    Cash provided by financing activities  5.173.285.480.1 

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy